Further studies have verified that IFI30 functions as an indispensable factor in the immune response of cancers, such as glioma (Chen et al., 2019), melanoma (Buetow et al., 2019) and breast cancer (Fan et al., 2021, 30). This evidence concerns the gene IFI30 and melanoma.